AMIT, Alfred Mann Institute at the Technion is involved in an active commercialization of Technion-born IP in Life Sciences. Currently managing five projects, four of which have become start-up companies.

When we decided to seek external financing for one of the subsidiaries, we engaged BioMarketing to assist us in generating a package for investors comprising of a Business Plan, Executive Summary and Investor Presentation.

We had many materials ready, but looked for someone with a good business perspective and experience, and found BioMarketing to be a good partner, quickly learning our products and ecosystem.  The process was a very good, constructive and based on a pleasant dialogue. We viewed BioMarketing as a part of our team, and in due time received all the deliverables, well meeting our expectations.

Definitely a very good partner for strategic thinking and analysis, and professionals in developing the relevant business materials!

- Dr. Zeev Gilkis, CEO